|
Market Closed -
Nasdaq
21:00:00 13/05/2026 BST
|
5-day change
|
1st Jan Change
|
|
44.40 USD
|
-0.29%
|
|
-2.63%
|
+22.48%
|
|
05-11 |
Evercore ISI Adjusts CSX Price Target to $46 From $44
|
MT
| |
04-28 |
Rothschild & Co Redburn Adjusts Price Target on CSX to $47.50 From $45.50, Maintains Buy Rating
|
MT
| |
04-28 |
Morgan Stanley Downgrades CSX to Underweight From Equalweight, Price Target is $30
|
MT
| |
04-23 |
CSX Turnaround Largely Reflected in Stock Valuation, Morgan Stanley Says in Downgrade
|
MT
| |
04-23 |
CSX Raises Growth, Margin Targets Under CEO Angel, BofA Says
|
MT
| |
04-23 |
CSX Positioned for Further Revenue and Margin Growth, RBC Says
|
MT
| |
04-23 |
CSX Turnaround Going Well, but Valuation Looks Stretched, Morgan Stanley Says
|
MT
| |
04-23 |
Evercore ISI Adjusts Price Target on CSX to $44 From $41, Maintains In Line Rating
|
MT
| |
04-23 |
TD Cowen Adjusts Price Target on CSX to $45 From $40, Maintains Buy Rating
|
MT
| |
04-23 |
Benchmark Adjusts Price Target on CSX to $48 From $46, Maintains Buy Rating
|
MT
| |
04-23 |
Baird Adjusts Price Target on CSX to $47 From $40, Maintains Outperform Rating
|
MT
| |
04-23 |
RBC Raises Price Target on CSX to $47 From $43, Keeps Outperform Rating
|
MT
| |
04-23 |
Raymond James Adjusts Price Target on CSX to $49 From $45, Maintains Outperform Rating
|
MT
| |
04-23 |
Barclays Adjusts Price Target on CSX to $47 From $40, Maintains Overweight Rating
|
MT
| |
04-23 |
Wells Fargo Adjusts Price Target on CSX to $50 From $40, Maintains Overweight Rating
|
MT
| |
04-23 |
JPMorgan Adjusts Price Target on CSX to $48 From $42, Maintains Overweight Rating
|
MT
| |
04-23 |
Jefferies Adjusts Price Target on CSX to $52 From $50, Maintains Buy Rating
|
MT
| |
04-23 |
Goldman Sachs Adjusts Price Target on CSX to $41 From $37, Maintains Neutral Rating
|
MT
| |
04-23 |
Citigroup Adjusts Price Target on CSX to $46 From $44, Maintains Neutral Rating
|
MT
| |
04-23 |
BMO Capital Adjusts Price Target on CSX to $45 From $40, Maintains Market Perform Rating
|
MT
| |
04-23 |
Morgan Stanley Downgrades CSX to Underweight From Equalweight, Price Target is $30
|
MT
| |
04-17 |
Benchmark Adjusts Price Target on CSX to $46 From $40, Maintains Buy Rating
|
MT
| |
04-15 |
Raymond James Adjusts CSX Price Target to $45 From $41, Maintains Outperform Rating
|
MT
| |
04-07 |
Citigroup Downgrades CSX to Neutral From Buy, Adjusts Price Target to $44 From $41
|
MT
| |
04-07 |
JPMorgan Adjusts Price Target on CSX to $42 From $41, Maintains Overweight Rating
|
MT
|
No results for this search
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|